Work

Involuntary Movements Following Administration of Hydroxychloroquine for COVID-19 Pneumonia

Year: 2020

Type: article

Abstract: Hydroxychloroquine (HCQ) has been used as an investigational drug for patients with moderate to severe coronavirus disease 2019 (COVID-19). There have been concerns of potential harms from side effects of the drug. We present a case of a 38-year-old male who was started on HCQ for COVID-19 pneumonia. He was referred for evaluation of myoclonus of all extremities, which resolved after discontinuation of HCQ. The involuntary movements were first reported after the initiation of HCQ, persisted despite improvement in inflammatory and radiologic parameters and eventually resolved after HCQ discontinuation. This supports a possible causality related to adverse drug reactions from HCQ that have not been commonly reported.

Source: Journal of Movement Disorders

DOI: 10.14802/jmd.20091

Authors: Emmaline Zantua Fernando, Jeryl Ritzi Tan Yu, Salvador Miclat Abad Santos, Roland Dominic Go Jamora

Institutions: St. Luke's Medical Center, Philippine General Hospital, University of the Philippines Manila

Language: English

Topic: Neurological and metabolic disorders

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W3111020009

FWCI: 0.508

Cites: 10

Cited by: 4

Related to: 10